At the 2026 Prix Galien USA Awards Ceremony, the Cochlear® Nucleus® Nexa® System is a finalist for Best Medical Technology.
Continue reading at AudiologyOnline
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is an industry award nomination with no new clinical data or practice guidance.
Award recognition signals industry and peer validation of next-generation cochlear implant technology, which may influence procurement decisions and patient awareness.
- 01Cochlear Nucleus Nexa System named a finalist for Best Medical Technology at 2026 Prix Galien USA.
- 02Prix Galien USA is a prestigious award recognizing innovation in medical technology.
- 03No new clinical evidence or efficacy data is presented in the announcement.
- 04Recognition may raise awareness among clinicians and patients considering cochlear implantation.
The Cochlear Nucleus Nexa System has been named a finalist for Best Medical Technology at the 2026 Prix Galien USA Awards.
press releasesupported